UNC study tests a single blood draw to screen for multiple cancers
UNC Lineberger is enrolling about 2,000 North Carolinians (ages 45–75) in the Vanguard Study to evaluate blood-based, multi-cancer detection tests that could screen for several cancers at once; while promising, these assays are not FDA-approved and not yet ready for routine screening, with results guiding a larger nationwide trial and potential future changes to cancer screening.
